ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 153

Palliative Care Curriculum in Rheumatology: Teaching Serious Illness Conversations

Marissa Karpoff1, Michael George 2 and Laura Dingfield 1, 1Hospital at the University of Pennsylvania, Philadelphia, 2University of Pennsylvania, Philadelphia

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: conversation and interdisciplinary rheumatology team, palliative

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Education Poster

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Palliative care is a specialty that focuses on holistic care, promoting quality of life, and providing an extra layer of support for patients and families alongside traditional medical treatment. While these principles are highly relevant to many patients seen by rheumatologists, palliative care education for rheumatologists has been limited. Our aim was to assess the baseline needs of rheumatologists in our division, present an educational program, and identify opportunities for adaptation and expansion of palliative care education.

Methods: We developed an educational program collaboratively with palliative care that was presented to Rheumatology faculty and fellows at the University of Pennsylvania in the fall of 2018. A needs assessment survey was developed based on well-known palliative care concepts to assess baseline skills and attitudes. A two-hour interactive session was held based on the established and validated “Serious Illness Care Program” created by Ariadne Labs, adapting content to rheumatology. This program includes teaching the “Serious Illness Conversation Guide” – a scripted set of questions to guide clinicians through a conversation that includes 1) setting up the conversation, 2) assessing patient understanding, 3) sharing information, 4) exploring patient goals, fears, strengths, wishes, and 5) closing. The session included a demonstration of how to utilize the Conversation Guide, break-out sessions to practice conversations led by palliative care specialists using rheumatology-specific cases, and a debrief. Two champions of the program were identified who trialed the guide in clinic over the following four months. All providers received a follow-up survey to evaluate the program.

Results: The needs assessment survey had 25/30 responses. No providers had received previous rheumatology-specific palliative care training and 36% had never received any palliative care training. 21 (84%) reported seeing patients for which they would not be surprised if the patient died within the next year. Few providers referred to hospice or discussed code status, and a minority regularly discussed patient goals/values or prognosis for these patients (Figure 1). Time and uncertainty in prognostication were the most significant barriers to these conversations. The two-hour session was attended by 27 providers. In the follow-up survey, >80% found the program to be interesting, appropriate in length, and appropriate in scope. Each component of the program was favorably rated (Figure 2). Although only two providers were designated as “champions,” 6 providers reported using the Conversation Guide in clinic. Time was the major barrier to using the guide.

Conclusion: This innovation was among the first to adapt a validated palliative care training program to a rheumatology division. The program was highly rated and led to use of the Conversation Guide in clinic. Further adaption of the Conversation Guide to rheumatology specific needs, scheduling changes to allow time for serious illness conversations in clinic, and assessment of benefits to patients are planned.

Figure 1

Figure 2


Disclosure: M. Karpoff, None; M. George, AbbVie, 5, Bristol Myers Squibb, 2, Bristol-Myers Squibb, 2; L. Dingfield, None.

To cite this abstract in AMA style:

Karpoff M, George M, Dingfield L. Palliative Care Curriculum in Rheumatology: Teaching Serious Illness Conversations [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/palliative-care-curriculum-in-rheumatology-teaching-serious-illness-conversations/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/palliative-care-curriculum-in-rheumatology-teaching-serious-illness-conversations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology